NCT07443761

Brief Summary

There is a need for a structured registry to collect real-world data on patient characteristics, surgical strategies, perioperative outcomes, and long-term results. Such a registry will provide insights into quality of care, support benchmarking, and form the basis for clinical and translational research.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
285mo left

Started Nov 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Nov 2025Jan 2050

Study Start

First participant enrolled

November 19, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 15, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 2, 2026

Completed
23.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2050

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2050

Last Updated

March 2, 2026

Status Verified

January 1, 2026

Enrollment Period

24.1 years

First QC Date

January 15, 2026

Last Update Submit

February 26, 2026

Conditions

Benign Pancreas TumorMalignant Pancreatic Neoplasm

Keywords

004516benign pancreas tumormalignant pancreatic neoplasmpancreaticoduodenectomydistal pancreatectomytotal pancreatectomycentral pancreatectomychronic pancreatitis

Outcome Measures

Primary Outcomes (1)

  • 90-day mortality

    90-day mortality

    25 years

Secondary Outcomes (1)

  • Establishment of a registry for patients undergoing pancreatic surgery - secondary outcome measures

    25 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing pancreatic surgery

You may qualify if:

  • benign indications for pancreatic surgery, including chronic pancreatitis, cystic lesions and IPMN
  • malignant indications for pancreatic surgery, including PDAC, duodenal carcinoma, pancreatic neuro-endocrine tumours, distal cholangiocarcinoma.

You may not qualify if:

  • indications for pancreatic resection caused by acute pancreatitis
  • pancreatic resection after abdominal trauma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Antwerp

Edegem, Antwerp, 2650, Belgium

Location

Related Publications (3)

  • Hartman V, Bracke B, Chapelle T, Hendrikx B, Liekens E, Roeyen G. Robotic Pancreaticoduodenectomy for Pancreatic Head Tumour: A Single-Centre Analysis. Cancers (Basel). 2024 Dec 20;16(24):4243. doi: 10.3390/cancers16244243.

    PMID: 39766142BACKGROUND

  • Ho CK, Kleeff J, Friess H, Buchler MW. Complications of pancreatic surgery. HPB (Oxford). 2005;7(2):99-108. doi: 10.1080/13651820510028936.

    PMID: 18333171BACKGROUND

  • PancreasGroup.org Collaborative. Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries. Br J Surg. 2024 Jan 3;111(1):znad330. doi: 10.1093/bjs/znad330.

    PMID: 38743040BACKGROUND

MeSH Terms

Conditions

Pancreatic NeoplasmsPancreatitis, Chronic

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System DiseasesPancreatitisChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2026

First Posted

March 2, 2026

Study Start

November 19, 2025

Primary Completion (Estimated)

January 1, 2050

Study Completion (Estimated)

January 1, 2050

Last Updated

March 2, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Full access to the dataset will be limited to the PI, co-PI and study coordinator. Site investigators may access the full dataset upon formal request, subject to approval by the steering group. Requests must include a description of their research plans for consideration.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
IPD would be available depending on the study...
Access Criteria
Full access to the dataset will be limited to the PI, co-PI and study coordinator. Site investigators may access the full dataset upon formal request, subject to approval by the steering group. Requests must include a description of their research plans for consideration.

Locations

BE(1)